Literature DB >> 76935

Hypoimmunoglobulinaemia with deficiency of pre-B cells.

A R Hayward.   

Abstract

No pre-B cells were found in the marrows of two girls with congenital antibody deficiency who lacked B cells. The presence of variable T-lymphocyte defects in these and thymoma patients lacking pre-B cells favours a metabolic aetiology rather than selective failure of a single cell series.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 76935     DOI: 10.1016/s0140-6736(78)90739-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  What is Good's syndrome? Immunological abnormalities in patients with thymoma.

Authors:  P Kelleher; S A Misbah
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

Review 2.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

3.  Pathogenesis of hypogammaglobulinaemia with thymoma and late-onset hypogammaglobulinaemia.

Authors:  G L Asherson; S Johnson; T A Platts-Mills; A D Webster
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

Review 4.  Immunodeficiency and general medicine.

Authors:  A M Denman
Journal:  Br Med J       Date:  1980-11-22

Review 5.  Pre-B cells; normal and abnormal development.

Authors:  M D Cooper
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

6.  Pre-B cell suppression by thymoma patient lymphocytes.

Authors:  A R Hayward; P Paolucci; A D Webster; P Kohler
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

7.  Lymphoid progenitor cells in severe combined immunodeficiency.

Authors:  S Neudorf; J Kersey; A Filipovich
Journal:  J Clin Immunol       Date:  1985-01       Impact factor: 8.317

8.  Defective cellular immune response in vitro in common variable immunodeficiency.

Authors:  S Cunningham-Rundles; C Cunningham-Rundles; F P Siegal; S Gupta; E M Smithwick; C Kosloff; R A Good
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.